Sitemap

  • Directive - Prescriptions
  • Directives Non Prescription
  • Directives - Pharmacovigilance
  • Directives - Laboratory & Quality Control
  • Directives - Vaccine Lot Release
  • Directives - Plasma Products Lot Release
  • Directives - Licensing
  • Training and Seminars
  • FAQ API
  • FAQ Generic
  • FAQ Biologics
  • FAQ NCE
  • FAQ Traditional
  • FAQ Health General
  • FAQ Combo Products
  • FAQ Bioequivalence(BE)
  • FAQ Cosmetic
  • FAQ Clinical Trial
  • FAQ Pharmacovigilance
  • FAQ GMP
  • FAQ Laboratory & Quality Control
  • Circular - Prescription
  • Circulars Biologics
  • Circulars NCE
  • Circulars Traditional
  • Circulars Health Supplements
  • Circulars - Non Prescription
  • Circulars - Veterinary
  • Circulars - Combo Products
  • Circulars - Cosmetics
  • Circulars - Clinical Trial
  • Circulars - Bioequivalence (BE)
  • Circulars - Active Pharmaceutical Ingredient (API)
  • Circulars - Pharmacovigilance
  • Circulars Plasma Products Lot Release
  • Circulars Vaccine Lot Release
  • Circulars Laboratory & Quality Control
  • Circulars GMP
  • Sebut Harga 2016
  • Announcement 2017
  • Publications
  • NPRA Publications
  • Announcement - Biologics
  • Announcement - NCE
  • Announcement - Traditional
  • Announcement - Health Supplements
  • Announcement - Veterinary
  • Announcement - Combo Products
  • Announcement - Bioequivalence(BE)
  • Announcement - Cosmetic
  • Announcement - Clinical Trial
  • Announcement - Pharmacovigilance
  • Announcement - GMP
  • Announcement - Laboratory & Quality Control
  • Safety Alerts Main
  • Industries
  • Traditional
  • Guidelines Central
  • Guidelines - Non Prescription
  • Guidelines - Clinical Trial
  • Guidelines - Vaccine Lot Release
  • Guidelines - Plasma Products Lot Release
  • Guidelines - Licensing
  • Guidelines - FEO
  • Application Form
  • Application Form - Prescriptions
  • Application Form - Biologics
  • Application Form - Non Prescription
  • Application Form - Bioequivalence(BE)
  • Application Form - Cosmetic
  • Application Form - Pharmacovigilance
  • Application Form - Laboratory & Quality Control
  • Application Form - Active Pharmaceutical Ingredient (API)
  • Application Form - Vaccine Lot Release
  • Application Form - Plasma Products Lot Release
  • Application Form - Licensing
  • Application Form - FEO
  • none
  • test
  • Press Release
  • Press Release 2016

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Friday 14 December 2018, 08:46:08.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA